Skip to content

Impact Evaluation of Personalized Oral Hygiene Education on Periodontal Patients Stage I/II/III

Impact Evaluation of Personalized Oral Hygiene Education on Periodontal Patients Stage I/II/III

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04745598
Acronym
HygParo
Enrollment
120
Registered
2021-02-09
Start date
2021-03-31
Completion date
2022-06-30
Last updated
2021-02-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Periodontal Disease Stage I/II/III

Brief summary

Evaluation of personalized oral hygiene education on plaque accumulation and gingival inflammation in periodontal patients stage I/II/III. Evaluation of personalized oral hygiene education on clinical attachment level in periodontal patients stage I/II/III. Evaluation of personalized oral hygiene education on the psychological determinants described by the Health Action Process Approach (HAPA) and the mediating role of these psychological determinants in oral hygiene habits and clinical parameters in periodontal patients stage I/II/III.

Interventions

BEHAVIORALControl group: Dental Model

\- Patients receive a demonstration of plaque control methods (modified Bass dental brushing technique and the use of the electric toothbrush) using a dental model.

BEHAVIORALComputer-assisted teaching format group

\- Patients receive a Powerpoint presentation containing:

BEHAVIORALPlaque-disclosing group

\- Patients place a few drops of a plaque-disclosing solution on the tongue and run the tongue over all the teeth and gums. With the aid of a hand mirror, patients can observe the stained plaque residue on their teeth

BEHAVIORALIntra-oral camera group

\- An ACTEON Soprocare® intraoral camera is used during the examination and explanation of oral hygiene strategies.

Sponsors

University Hospital, Strasbourg, France
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* ≥ 18 years old * Subject having signed an informed consent * Subjects with periodontal disease Stage I/II/III : * ≥ 15 teeth/implants * Bleeding index at ≥ 25% * Plaque index ≥ 20% * Not requiring antibiotic prophylaxis prior to periodontal treatment. * Not having received surgical periodontal treatment in the last 12 months. * Smokers of ≤10 cigarettes/day

Exclusion criteria

* \<15 teeth/implants * Physical or mental disability that does not allow for the performance of oral hygiene procedures. * Chronic progressive pathology (diabetes...) / immunodeficiencies (HIV...)/ systemic infections. * Ongoing drug treatment leading to a significant change in the periodontal condition (anti-epileptics, calcium antagonists, immunosuppressants, hormonal treatments, etc.). * Ongoing drug treatment that can influence the periodontal condition (anti-inflammatory drugs, antibiotics) * Patients with severe xerostomia or with Gougerot-Sjögren's syndrome. * Subjects undergoing treatment for cancer * Pregnant or breastfeeding women * Smokers of \> 10 cigarettes/day * Impossibility to give information about the subject (subject in an emergency situation, difficulties in understanding the French language, etc.). * Subject under safeguard of justice * Subject under guardianship or curatorship

Design outcomes

Primary

MeasureTime frameDescription
Evaluation of the plaque index3 monthsPlaque Index (Loë and Silness, 1963): Six surfaces per tooth (buccal, mesio-buccal, disto-buccal, lingual, mesio-lingual and disto-lingual) are examined in every permanent tooth (except for third molars). Each tooth is assessed with a score between 0 and 3. * 0 : absence of dental plaque * 1 : plaque disclosed after running the periodontal probe along the gingival margin * 2: visible plaque; absence of plaque in the interdental spaces * 3: abundant plaque; presence of plaque in the interdental spaces
Evaluation of the gingival index3 monthsGingival Index (Loë 1967): Six surfaces per tooth (buccal, mesio-buccal, disto-buccal, lingual, mesio-lingual and disto-lingual) are examined in every permanent tooth (except for third molars). * 0: absence of visual signs of inflammation * 1 : slight change in color and texture o 2: Visual inflammation and bleeding tendency from the gingival margin right after a periodontal probe is briefly run along the gingival margin * 3: Overt inflammation with tendency for spontaneous bleeding

Secondary

MeasureTime frameDescription
Evaluation of probing pocket depth3 monthsProbing pocket depth (distance from the top of the marginal gingiva to the bottom of the pocket)
Evaluation of the gingival attachment level3 monthsGingival attachment level (distance separating the cemento-enamel junction from the bottom of the pocket)
Psychological determinants of the HAPA (Health Action Process Approach)3 monthsChange in the psychological determinants of the HAPA questionnaire adapted to oral health, using a 7-point Likert scale from strongly disagree (1) to strongly agree (7)

Countries

France

Contacts

Primary ContactOlivier HUCK
olivier.huck@chru-strasbourg.fr+33 3 88 11 69 47

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026